FDA approval may not be far off. Before then you will see a rescheduling.
Rescheduling will likely happen this year. In fact, natural THC has already been rescheduled this year, as long as it mirrors the synthetic THC.
The FDA is going to be forced to make some changes....not by scientific review but by political rule.
It is possible that before FDA allows sanctioned clinical trials, CBIS gets bought before out then. Companies like Sanofi-Aventis are looking for exactly what CBIS is offering. Sanofi-Aventis even has video on youtube describing the wonders of the endocannabiniod systems and looking for generic drug to fill out there profile of products.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.